Search

Search Constraints

You searched for: Author/Creator Chihara, Yusuke

Search Results

1. A Phase II Study of S‐1 and Paclitaxel Combination Therapy as a First‐Line Treatment in Elderly Patients with Advanced Non‐Small Cell Lung Cancer. (21st December 2018)

2. Clinical impact of pembrolizumab combined with chemotherapy in elderly patients with advanced non-small-cell lung cancer. (November 2021)

3. Comparing three different anti-PD-L1 antibodies for immunohistochemical evaluation of small cell lung cancer. (November 2019)

4. Diagnostic significance of secondary bacteremia in patients with COVID-19. Issue 4 (April 2023)

5. High levels of AXL expression in untreated EGFR‐mutated non‐small cell lung cancer negatively impacts the use of osimertinib. Issue 2 (11th November 2022)

6. Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non‐small cell lung cancer. Issue 3 (21st January 2019)

7. Impact of cancer cachexia on the therapeutic outcome of combined chemoimmunotherapy in patients with non-small cell lung cancer: a retrospective study. (1st January 2021)

8. Impact of docetaxel plus ramucirumab in a second‐line setting after chemoimmunotherapy in patients with non‐small‐cell lung cancer: A retrospective study. Issue 2 (17th November 2021)

9. Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M‐Positive Non‐Small‐Cell Lung Cancer Who Progressed During Prior Treatment: A Phase II Trial. (16th January 2019)

10. Phase II Study of S‐1 and Paclitaxel Combination Therapy in Patients with Previously Treated Non‐Small Cell Lung Cancer. (30th April 2019)